Literature DB >> 17113751

Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1.

Sachie Asada1, Hiroaki Daitoku, Hitomi Matsuzaki, Tomoko Saito, Tatsuhiko Sudo, Hidehito Mukai, Shintaro Iwashita, Koichiro Kako, Tsutomu Kishi, Yoshitoshi Kasuya, Akiyoshi Fukamizu.   

Abstract

The members of the transcription factor Foxo family regulate the expression of genes concerned with the stress response, cell cycle and gluconeogenesis. Foxo1 (FKHR) contains 15 consensus phosphorylation sites for the mitogen-activated protein kinase (MAPK) family. Therefore, we hypothesized that MAPKs could directly regulate the transcriptional activity of Foxo1 via phosphorylation. In vitro kinase assay showed that Foxo1 was phosphorylated by extracellular signal-regulated kinase (Erk) and p38 MAPK (p38) but not by c-jun NH2-terminal kinase (JNK). In NIH3T3 cells, epidermal growth factor or anisomycin increased phosphorylation of exogenous Foxo1, which was significantly inhibited by pretreatment with an MEK 1 inhibitor, PD98059, or a p38 inhibitor, SB203580. Two-dimensional phosphopeptide mapping using mutation of phosphorylation sites for MAPK revealed that the nine serine residues in Foxo1 are specifically phosphorylated by Erk and that five of the nine residues are phosphorylated by p38 in vivo. Moreover, we also found that Foxo1 interacts with Ets-1 and functions as a coactivator for Ets-1 on the fetal liver kinase (Flk)-1 promoter in bovine carotid artery endothelial cells. Mutation of the nine phosphorylation sites for Erk in Foxo1 was shown to lead to less binding and synergistic activity for Ets-1 on the Flk-1 promoter when compared with wild-type Foxo1. These results suggest that Foxo1 is specifically phosphorylated by Erk and p38, and that this phosphorylation regulates the function of Foxo1 as a coactivator for Ets-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113751     DOI: 10.1016/j.cellsig.2006.08.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  99 in total

1.  Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.

Authors:  Xunqin Yin; Mary Ellen Pavone; Zhenxiao Lu; JianJun Wei; J Julie Kim
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

2.  Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization.

Authors:  Li Qiang; Alexander S Banks; Domenico Accili
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

3.  Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle.

Authors:  Malgorzata Milkiewicz; Emilie Roudier; Jennifer L Doyle; Anastassia Trifonova; Olivier Birot; Tara L Haas
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  Running on empty: how p53 controls INS/IGF signaling and affects life span.

Authors:  Heidi Scrable; Silvia Medrano; Erica Ungewitter
Journal:  Exp Gerontol       Date:  2008-06-13       Impact factor: 4.032

Review 5.  Insulin regulation of gluconeogenesis.

Authors:  Maximilian Hatting; Clint D J Tavares; Kfir Sharabi; Amy K Rines; Pere Puigserver
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

6.  FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol.

Authors:  Rakesh K Srivastava; Terry G Unterman; Sharmila Shankar
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

7.  Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1.

Authors:  Ushma R Jag; Jiri Zavadil; Frederick M Stanley
Journal:  Mol Endocrinol       Date:  2009-07-16

8.  ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.

Authors:  Jer-Yen Yang; Cong S Zong; Weiya Xia; Hirohito Yamaguchi; Qingqing Ding; Xiaoming Xie; Jing-Yu Lang; Chien-Chen Lai; Chun-Ju Chang; Wei-Chien Huang; Hsin Huang; Hsu-Ping Kuo; Dung-Fang Lee; Long-Yuan Li; Huang-Chun Lien; Xiaoyun Cheng; King-Jen Chang; Chwan-Deng Hsiao; Fuu-Jen Tsai; Chang-Hai Tsai; Aysegul A Sahin; William J Muller; Gordon B Mills; Dihua Yu; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2008-01-20       Impact factor: 28.824

9.  Modelling the response of FOXO transcription factors to multiple post-translational modifications made by ageing-related signalling pathways.

Authors:  Graham R Smith; Daryl P Shanley
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

10.  Negative regulators of insulin signaling revealed in a genome-wide functional screen.

Authors:  Shih-Min A Huang; Michael K Hancock; Jeffrey L Pitman; Anthony P Orth; Nicholas Gekakis
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.